Evidence map›Paper›PMID 42904531›Full record

ArticleThe journal of adhesive dentistry2026

Do Amelogenin Peptide-Based Nanohydrogels Prevent Artificially Induced White Spot Lesions?

Maryam Shakir, Harraa S Mohammed-Salih, Falah H Hussein, Jameel R Al-Obaidi

Abstract read
In one paragraph

Article in The journal of adhesive dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maryam Shakir
Harraa S Mohammed-Salih
Falah H Hussein
Jameel R Al-Obaidi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs one of the most undesirable side effects of fixed orthodontic treatment, the occurrence of white spot lesions should be prevented. In the present study, amelogenin peptide combined with hydroxyapatite nanoparticles within chitosan hydrogels was formulated to prevent enamel demineralization. METHODS AND MATERIALS: Three groups were evaluated for the evaluation of preventive effects. The first group received no treatment and was considered a control group, while the other groups were the experimental groups with the intervention. The first experimental group was treated with chitosan-based hydrogel including the peptide, while the other group was treated with the application of equal amounts of chitosan-based hydrogels loaded with either peptide or hydroxyapatite. pH cycling was carried out for two weeks. The preventive potential was evaluated through the estimation of enamel microhardness, fluorescence, and X-ray diffraction. The surface characteristics of sound and treated enamel were evaluated by scanning electron microscopy using different magnifications, and the chemical compositions were analyzed by an energy-dispersive X-ray spectroscopic analyzer.

resultsThe results revealed the preventive potential of amelogenin peptide combined with hydroxyapatite through the preservation and improvement of appearance, and mechanical and chemical characteristics of the enamel surface throughout pH cycling.

conclusionThis study concludes that the amelogenin peptide combined with hydroxyapatite nanoparticles within chitosan hydrogels provides a promising preventive strategy.

Indexed as

AmelogeninDental CariesDurapatiteHydrogelsNanoparticlesPeptidesTooth DemineralizationAnimalsChitosanDental EnamelHardnessHumansHydrogen-Ion ConcentrationMicroscopy, Electron, ScanningSpectrometry, X-Ray EmissionSurface PropertiesAmelogeninChitosanDurapatiteHydrogelsPeptidesamelogenin peptidechitosanenamel remineralizationnanohydrogel

Identifiers

PMID42904531
PMCPMC13685533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.